From peptide therapies to vitamin infusions, we provide treatments that work from the inside out
Insurance providers recognize bariatric surgery as: Medically necessary for qualifying patients Cost-effective over time Supported by decades of outcomes data For patients frustrated by denials or escalating costs of GLP-1 medications, bariatric surgery may represent a more predictable and sustainable insurance-approved option
PlexusDx exclusively partners with licensed 503A compounding pharmacies to provide customized semaglutide, tirzepatide, and GLP-Squared dual compounds
Some compounded or speciality formulations use different concentrations (100 mg/mL or 250 mg/mL) which alter the unit calculation
Other Ingredients: microcrystalline cellulose, hypromellose (vegetarian capsule), silica
LRRK2 inhibition by BIIB122 in healthy participants and patients with Parkinsons disease